Gene-editing patents have increased tenfold in just four years. Here’s what the technology could cure CRISPR gene-editing trials have taken off—and may hold the key to medical breakthroughs.

Over the weekend, Intellia sought to address concerns in the gene editing community about accidental germline transmission.

In the decade since the publication of CRISPR-Cas9 as a genome editing technology, the CRISPR toolbox and its applications have profoundly changed biological research, enabling advances through ...

Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.